Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement

被引:78
作者
McLean, TW
Fisher, CJ
Snively, BM
Chauvenet, AR
机构
[1] Wake Forest Univ, Sch Med, Dept Pediat, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
D O I
10.1200/JCO.2005.12.097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose In pediatric patients with acute lymphoblastic leukemia (ALL), the optimal time for central venous line (CVL) insertion and the optimal type of CVL (internal v external) is unclear. This study was undertaken to compare complication rates between early versus late line insertion, and between internal versus external lines in children with lesser risk ALL. Patients and Methods We performed a retrospective analysis of patients enrolled onto Pediatric Oncology Group (POG) protocol 9201. Data regarding demographics, CVL types and insertion dates, blood counts, and complications were reviewed through week 25 of therapy. Results Of 697 patients enrolled onto POG protocol 9201, 362 patients had sufficient data for analysis. When compared to late line placement (> day 15 of induction), early CVL placement (<= day 15 of induction) was associated with an increased risk of having a positive blood culture (odds ratio, 2.2; 95% CI, 1.0 to 5.0; P = .05). When compared with internal CVLs ("ports"), external CVLs were associated with a positive blood culture (odds ratio, 3.1; 95% CI, 1.3 to 7.5; P = .01), thrombosis (odds ratio, 3.9; 95% CI, 1.5 to 10.3; P = .006), and CVL removal (odds ratio, 5.6; 95% CI, 2.7 to 11.6; P < .001). Conclusion In pediatric patients with lesser risk ALL, internal lines (ports) should be the preferred CVL type due to a lower risk of infectious and thrombotic complications. In addition, CVLs placed early in induction are associated with a higher risk of positive blood culture than those placed later in induction.
引用
收藏
页码:3024 / 3029
页数:6
相关论文
共 29 条
[1]   Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study [J].
Abbas, AAH ;
Fryer, CJH ;
Paltiel, C ;
Chedid, F ;
Felimban, SK ;
Yousef, AA ;
Khattab, TM .
PEDIATRIC BLOOD & CANCER, 2004, 42 (04) :325-331
[2]   A PROSPECTIVE-STUDY OF PROLONGED CENTRAL VENOUS ACCESS IN LEUKEMIA [J].
ABRAHM, JL ;
MULLEN, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (21) :2868-2873
[3]   LONG-TERM USE OF INDWELLING MULTIPURPOSE SILASTIC CATHETERS IN PEDIATRIC CANCER-PATIENTS TREATED WITH AGGRESSIVE CHEMOTHERAPY [J].
CAIRO, MS ;
SPOONER, S ;
SOWDEN, L ;
BENNETTS, GA ;
TOWNE, B ;
HODDER, F .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :784-788
[4]   Conditions associated with infections of indwelling central venous catheters in cancer patients: A summary [J].
Castagnola, E ;
Molinari, AC ;
Fratino, G ;
Viscoli, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) :233-239
[5]  
DAWSON S, 1991, AM J PEDIAT HEMATOL, V13, P126
[6]  
DECKER MD, 1988, PEDIATR CLIN N AM, V35, P579
[7]   LACK OF ASSOCIATION BETWEEN NEUTROPENIA AND THE INCIDENCE OF BACTEREMIA ASSOCIATED WITH INDWELLING CENTRAL VENOUS CATHETERS IN FEBRILE PEDIATRIC CANCER-PATIENTS [J].
GORELICK, MH ;
OWEN, WC ;
SEIBEL, NL ;
REAMAN, GH .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (07) :506-510
[8]   Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: A prospective randomized clinical trial [J].
Hanna, H ;
Benjamin, R ;
Chatzinikolaou, I ;
Alakech, B ;
Richardson, D ;
Mansfield, P ;
Dvorak, T ;
Munsell, MF ;
Darouiche, R ;
Kantarjian, H ;
Raad, I .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3163-3171
[9]  
HOWELL PB, 1995, CANCER, V75, P1367, DOI 10.1002/1097-0142(19950315)75:6<1367::AID-CNCR2820750620>3.0.CO
[10]  
2-Z